-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Artiva Biotherapeutics, Inc. annual/quarterly Operating Income (Loss) history and growth rate from Q2 2023 to Q3 2024.
- Artiva Biotherapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$18.3M, a 270% decline year-over-year.
- Artiva Biotherapeutics, Inc. annual Operating Income (Loss) for 2024 was -$67.3M, a 119% decline from 2023.
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)